Lumley’s silver turns to gold for trauma

20 February 2003
| By Ben Abbott |

Money Management/Dexx&r Adviser Choice Risk Awards

Best Trauma Products

Winner: Lumley Life - Medical Catastrophe Silver

Finalist: Lumley Life - Critical Illness

Finalist: Cominsure (Colonial) - Trauma

VALUE for money was the key factor in Lumley Life’s Medical Catastrophe Silver taking the trauma product blue ribbon in theMoney Management/Dexx&rAdviser Choice Risk Awards.

Dexx&r managing director Mark Kachor says that when the product’s premiums were balanced against its range of features and strong definitions, the policy came at a very reasonable price.

“There are cheaper products in the marketplace but they don’t offer the same features and definitions. There are also dearer products, but they don’t offer the same value,” he says.

Kachor says one of Medical Catastrophe Silver’s stand-out features was its generous and contemporary definitions that did not contain an extensive list of exclusions.

Lumley Life general manager sales and marketing Howard Davy says the success of its products including Medical Catastrophe Silver comes from regularly upgrading them with the help of advisers and passing the benefits on to existing policy holders.

“Over the years we have enhanced definitions all along the way, putting us at the cutting edge of certain medical conditions through these upgrades,” he says.

Davy says Lumley maintains the relative good value of its products through prudent underwriting and claims management.

“We do sound underwriting up-front, not at the claims stage, and have a sound reputation in the marketplace for our claims management process,” he says.

As a result, Lumley Life’s Critical Illness product was also rated good value by Kachor, coming in as a finalist.

Kachor says the product had a reasonable range of features, and though its definitions were much more restrictive, what set it apart was its low cost.

“It is not the cheapest but among the cheapest in marketplace, and its score has been boosted by this low cost,” he says.

Cominsure’s Trauma, also ranked as a finalist, is a reasonably fully featured product in the industry, according to Kachor.

He says although the pricing of the product is at the more expensive end of the market it was still competitive for the range of cover and definitions provided.

Though these three products have been singled out in the awards, Kachor says there are only fine differences between the top products in the trauma category with none coming out “head and shoulders” above the rest.

Kachor says this is indicative of the trauma market, which, while growing at a rapid rate, has suffered from a lack of product innovation in recent times.

“It has reached a point where there is similar cover throughout the industry, with companies competing in areas such as minor illnesses, even though these don’t affect many people,” he says.

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

3 weeks 4 days ago

This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...

1 month ago

Interesting. Would be good to know the details of the StrategyOne deal....

1 month ago

Insignia Financial has confirmed it is considering a preliminary non-binding proposal received from a US private equity giant to acquire the firm. ...

1 week 2 days ago

Six of the seven listed financial advice licensees have reported positive share price growth in 2024, with AMP and Insignia successfully reversing earlier losses. ...

5 days 12 hours ago

Specialist wealth platform provider Mason Stevens has become the latest target of an acquisition as it enters a binding agreement with a leading Sydney-based private equi...

4 days 16 hours ago